Related references
Note: Only part of the references are listed.Resistance to fluoroquinolones and second-Line injectable drugs: impact on multidrug-resistant TB outcomes
Dennis Falzon et al.
EUROPEAN RESPIRATORY JOURNAL (2013)
Compassionate use of and expanded access to new drugs for drug-resistant tuberculosis
C. R. Horsburgh et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2013)
Strategies for reducing treatment default in drug-resistant tuberculosis: systematic review and meta-analysis
A. Toczek et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2013)
Multidrug resistance in new tuberculosis patients: burden and implications
S. Royce et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2013)
Successful management of multidrug-resistant tuberculosis under programme conditions in the Dominican Republic
M. Rodriguez et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2013)
Substandard and falsified anti-tuberculosis drugs: a preliminary field analysis
R. Bate et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2013)
Old Drugs, New Purpose: Retooling Existing Drugs for Optimized Treatment of Resistant Tuberculosis
Kelly E. Dooley et al.
CLINICAL INFECTIOUS DISEASES (2012)
Pharmacokinetic/pharmacodynamic parameters and the choice of high-dosage rifamycins
D. A. Mitchison
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2012)
Tuberculosis, Drug Resistance, and the History of Modern Medicine
Salmaan Keshavjee et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Multidrug Resistant Pulmonary Tuberculosis Treatment Regimens and Patient Outcomes: An Individual Patient Data Meta-analysis of 9,153 Patients
Shama D. Ahuja et al.
PLOS MEDICINE (2012)
Short, Highly Effective, and Inexpensive Standardized Treatment of Multidrug-resistant Tuberculosis
Armand Van Deun et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)
Treatment Outcomes among Patients with Extensively Drug-Resistant Tuberculosis: Systematic Review and Meta-Analysis
Karen R. Jacobson et al.
CLINICAL INFECTIOUS DISEASES (2010)
Management of multidrug-resistant tuberculosis: an update
Ignacio Monedero et al.
Therapeutic Advances in Respiratory Disease (2010)
Pharmacology of second-line antituberculosis drugs and potential for interactions with antiretroviral agents
Katherine M. Coyne et al.
AIDS (2009)
Treatment outcomes among patients with multidrug-resistant tuberculosis: systematic review and meta-analysis
Evan W. Orenstein et al.
LANCET INFECTIOUS DISEASES (2009)
Treatment Outcomes of Multidrug-Resistant Tuberculosis: A Systematic Review and Meta-Analysis
James C. Johnston et al.
PLOS ONE (2009)
Effect of Duration and Intermittency of Rifampin on Tuberculosis Treatment Outcomes: A Systematic Review and Meta-Analysis
Dick Menzies et al.
PLOS MEDICINE (2009)
MDR-/XDR-TB management: what it was, current standards and what is ahead
Ignacio Monedero et al.
Expert Review of Respiratory Medicine (2009)
Drug-susceptibility testing in TB: current status and future prospects
Elvira Richter et al.
Expert Review of Respiratory Medicine (2009)
Management of multildrug-resistant tuberculosis and patients in retreatment
JA Caminero
EUROPEAN RESPIRATORY JOURNAL (2005)
Drug-susceptibility testing in tuberculosis: Methods and reliability of results
SJ Kim
EUROPEAN RESPIRATORY JOURNAL (2005)
Aminoglycoside toxicity: Daily versus thrice-weekly dosing for treatment of mycobacterial diseases
CA Peloquin et al.
CLINICAL INFECTIOUS DISEASES (2004)
Impact of DOTS compared with DOTS-plus on multidrug resistant tuberculosis and tuberculosis deaths: decision analysis
TR Sterling et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
Share Paper
